WHO issues medical product alert on Marion’s syrups
The WHO has issued a Medical Product Alert on India’s Marion Biotech’s Ambronol and DOK-1 Max syrups as they failed to meet quality.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
The WHO has issued a Medical Product Alert on India’s Marion Biotech’s Ambronol and DOK-1 Max syrups as they failed to meet quality.
https://oag.ca.gov/news/press-releases/attorney-general-bonta-sues-nations-largest-insulin-makers-pharmacy-benefit
Insilico Medicine, an AI biotech company, announced positive results from the Phase 1 clinical trial of INS018_055, its first-in-class drug for idiopathic pulmonary fibrosis.
If you are in a hospital, then at times, you get bacterial infections from one source — yourself.
In overweight or obese people, a defect in an enzyme, APT1, interferes with the ability to secrete insulin resulting in Type 2 diabetes,.
The number of sequences to detect the presence of the Covid-19 viral genome, being shared with WHO, has dropped by more than 90%,.
Indian drug major Sun Pharmaceutical’s western Indian facility of Halal has been issued a warning letter by the FDA for not conforming to Current Good.
A child or youth died every 4.4 seconds in 2021 and about five million children died before their fifth birthday, due to labor.
AstraZeneca, a British-Swedish global pharmaceutical and biotechnology company, will buy CinCor Pharma, Inc., for $1.8 billion, according to a statement.
Researchers have found that dietary supplement Tricaprin can help reverse heart disease due to plaque deposit